Primers were designed for hotspot regions in the KRAS (codon 12 and 13) and GNAS (codon 201) genes to detect well-characterized driver mutations in pancreatic cancer by Sanger sequencing. This evidence concerns the gene GNAS and pancreatic neoplasm.